Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03019185
Brief Title: A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL (CARDINAL)

First Submitted : January 6, 2017
First Submitted that Met QC Criteria : January 10, 2017
First Posted : January 12, 2017 (Estimate)

Certification/Extension First Submitted : September 22, 2021
Certification/Extension First Submitted that Met QC Criteria : September 22, 2021
Certification/Extension First Posted : September 28, 2021

Last Update Submitted that Met QC Criteria : September 22, 2021
Last Update Posted : September 28, 2021